Walleye Capital LLC Myriad Genetics Inc Transaction History

Walleye Capital LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $235,176 - $360,457	16,907 Added 5266.98%	17,228 $329,000
Q3 2023 Nov 14, 2023	BUY	$15.99 - $23.22 $5,132 - $7,453	321 New	321 $5,000
Q1 2023 May 15, 2023	SELL	$15.26 - $23.75 $198,029 - $308,203	-12,977 Reduced 33.17%	26,149 $607,000
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $259,438 - $375,301	17,880 Added 84.16%	39,126 $567,000
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $386,889 - $592,338	21,246 New	21,246 $405,000
Q2 2022 Aug 08, 2022	SELL	$16.45 - $25.88 $260,765 - $410,249	-15,852 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$22.67 - $28.01 $359,364 - $444,014	15,852 New	15,852 $399,000
Q4 2021 Mar 03, 2022	SELL	$24.13 - $32.63 $178,103 - $240,842	-7,381 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $221,208 - $270,587	7,381 New	7,381 $238,000
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $560,746 - $911,673	-46,114 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $273,240 - $358,248	24,288 Added 111.28%	46,114 $601,000
Q2 2020 Aug 14, 2020	SELL	$10.69 - $16.49 $33,716 - $52,009	-3,154 Reduced 12.63%	21,826 $248,000
Q1 2020 May 15, 2020	BUY	$9.78 - $29.53 $241,781 - $730,040	24,722 Added 9582.17%	24,980 $358,000
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $3,306 - $5,545	158 Added 158.0%	258 $7,000
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $2,208 - $4,708	100 New	100 $3,000
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $6,801 - $10,500	-300 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $8,079 - $10,410	300 New	300 $10,000

250

90.6M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.01B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.